Evidence map›Paper›PMID 12728643›Full record

ReviewCurrent diabetes reports2003

Lessons for human diabetes from experimental mouse models.

Rohit N Kulkarni, Ariel Zisman

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current diabetes reports, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rohit N KulkarniJoslin Diabetes Center, One Joslin Place, Room 602, Boston, MA 02215, USA. Rohit.Kulkarni@joslin.harvard.edu
Ariel Zisman
Joslin Diabetes Center · US

Funding

INSULIN &GLUCOSE SIGNALING PATHWAYS IN ISLET BETA CELLSK08DK002885 · NIDDK · JOSLIN DIABETES CENTER · PI KULKARNI, ROHIT N. · 2000 to 2004
$540k
NIDDK NIH HHS DK 02885-03
6 · The paper itself

Abstract

A precise knowledge of the defects underlying type 1 and type 2 diabetes is essential for designing appropriate therapeutic strategies. Because experiments in humans are limited, naturally occurring, and especially genetically engineered rodent models, have revolutionized research in diabetes. We review some of the models created recently and discuss their impact on human diabetes.

Indexed as

AnimalsCytokinesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Disease Models, AnimalGenetic TherapyHistocompatibility Antigens Class IIHumansImmune ToleranceInsulinIslets of LangerhansMiceMice, TransgenicCytokinesHistocompatibility Antigens Class IIInsulin

Identifiers

PMID12728643
OpenAlexW2123307879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.